| 注册
首页|期刊导航|中国医学前沿杂志(电子版)|GLOBOCAN 2022全球癌症统计数据解读

GLOBOCAN 2022全球癌症统计数据解读

曹梦迪 陈万青

中国医学前沿杂志(电子版)2024,Vol.16Issue(6):1-5,5.
中国医学前沿杂志(电子版)2024,Vol.16Issue(6):1-5,5.DOI:10.12037/YXQY.2024.06-01

GLOBOCAN 2022全球癌症统计数据解读

Interpretation on the global cancer statistics of GLOBOCAN 2022

曹梦迪 1陈万青1

作者信息

  • 1. 国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院 癌症早诊早治办公室,北京 100021
  • 折叠

摘要

Abstract

In February 2024,International Agency for Research on Cancer(IARC)released the latest global cancer statistics,GLOBOCAN 2022,which estimated the latest data on the number/rates of incidence and deaths of 36 types of cancer in 185 countries/regions around the world,described differences in the burden of cancer by countries/regions and gender,and provided projections of the cancer burden up to 2050.The GLOBOCAN 2022 data showed that in 2022,there were an estimated 19 976 499 new cancer cases and 9 743 832 cancer deaths worldwide.Lung cancer was the most common cancer worldwide,with 2 480 675 cases in 2022,accounting for 12.4%of all cancer cases,followed by breast cancer(11.5%),colorectal cancer(9.6%),prostate cancer(7.3%)and stomach cancer(4.9%).Lung cancer remained the leading cause of cancer deaths,with an estimated 1 817 469 deaths,accounting for 18.7%of overall cancer deaths,followed by colorectal cancer(9.3%),liver cancer(7.8%),breast cancer(6.8%)and stomach cancer(6.8%).Demographics-based projections indicate that by 2050,there will be 35.28 million new cancer cases globally,a 76.6%increase from 2022 levels.There are significant regional and gender differences in global cancer incidence and mortality.In this article,the main contents of the updated database are sorted out and interpreted.

关键词

GLOBOCAN 2022/癌症/发病/死亡/全球估计

Key words

GLOBOCAN 2022/Cancer/Incidence/Mortality/Global estimates

引用本文复制引用

曹梦迪,陈万青..GLOBOCAN 2022全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2024,16(6):1-5,5.

中国医学前沿杂志(电子版)

OA北大核心CSTPCD

1674-7372

访问量0
|
下载量0
段落导航相关论文